General Information of Drug (ID: DMM9WB0)

Drug Name
2-(3-(3,5-dichlorophenyl)ureido)benzoic acid
Synonyms CHEMBL1088742; 2-{[(3,5-dichlorophenyl)carbamoyl]amino}benzoic acid; 2-(3-(3,5-dichlorophenyl)ureido)benzoic acid; SCHEMBL11983339; MolPort-011-309-281; BDBM50313600; AKOS012857299
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 325.1
Logarithm of the Partition Coefficient (xlogp) 4.5
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 3
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C14H10Cl2N2O3
IUPAC Name
2-[(3,5-dichlorophenyl)carbamoylamino]benzoic acid
Canonical SMILES
C1=CC=C(C(=C1)C(=O)O)NC(=O)NC2=CC(=CC(=C2)Cl)Cl
InChI
InChI=1S/C14H10Cl2N2O3/c15-8-5-9(16)7-10(6-8)17-14(21)18-12-4-2-1-3-11(12)13(19)20/h1-7H,(H,19,20)(H2,17,18,21)
InChIKey
PIWYMPXOKMFVER-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
44631845
TTD ID
D03QKF

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Plasmodium Dihydroorotate dehydrogenase (Malaria DHOdehase) TT3PQ2Y PYRD_PLAF7 Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Discovery of novel inhibitors for DHODH via virtual screening and X-ray crystallographic structures. Bioorg Med Chem Lett. 2010 Mar 15;20(6):1981-4.